Literature DB >> 30834824

National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism.

Ayman Elbadawi1, Amgad Mentias2, Islam Y Elgendy3, Ahmed H Mohamed4, Mohammed Hz Syed4, Gbolahan O Ogunbayo5, Odunayo Olorunfemi4, Igor Gosev6, Sunil Prasad6, Scott J Cameron6,7.   

Abstract

Little is known about the temporal trends and outcomes for extra-corporeal membrane oxygenation (ECMO) in patients with high-risk pulmonary embolism (PE) in the United States. We queried the National Inpatient Sample (NIS) database from 2005 to 2013 to identify patients admitted with high-risk PE. Our objective was to determine trends for ECMO use in patients with high-risk PE. We also assessed in-hospital outcomes among patients with high-risk PE receiving ECMO. We evaluated 77,809 hospitalizations for high-risk PE. There was an upward trend in the utilization of ECMO from 0.07% in 2005 to 1.1% in 2013 ( p = 0.015). ECMO was utilized more in urban teaching hospitals and large hospitals. ECMO use was associated with lower mortality in patients with massive PE ( p < 0.001). In-hospital mortality for patients receiving ECMO was 61.6%, with no change over the observational period ( p = 0.68). Our investigation revealed several independent predictors of increased mortality in patients with high-risk PE using ECMO as hemodynamic support, including: age, female sex, obesity, congestive heart failure, and chronic pulmonary disease. ECMO, therefore, as a rescue strategy or bridge to definitive treatment, may be effective in the management of high-risk PE when selecting patients with favorable clinical characteristics.

Entities:  

Keywords:  extra-corporeal membrane oxygenation (ECMO); high-risk pulmonary embolism (PE); respiratory failure; shock

Mesh:

Year:  2019        PMID: 30834824      PMCID: PMC6527463          DOI: 10.1177/1358863X18824650

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  19 in total

1.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

2.  Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases.

Authors:  Nicolas Meneveau; Benoit Guillon; Benjamin Planquette; Gaël Piton; Antoine Kimmoun; Lucie Gaide-Chevronnay; Nadia Aissaoui; Arthur Neuschwander; Elie Zogheib; Hervé Dupont; Sebastien Pili-Floury; Fiona Ecarnot; François Schiele; Nicolas Deye; Nicolas de Prost; Raphaël Favory; Philippe Girard; Mircea Cristinar; Alexis Ferré; Guy Meyer; Gilles Capellier; Olivier Sanchez
Journal:  Eur Heart J       Date:  2018-12-14       Impact factor: 29.983

3.  Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.

Authors:  Matthieu Schmidt; Aidan Burrell; Lloyd Roberts; Michael Bailey; Jayne Sheldrake; Peter T Rycus; Carol Hodgson; Carlos Scheinkestel; D Jamie Cooper; Ravi R Thiagarajan; Daniel Brodie; Vincent Pellegrino; David Pilcher
Journal:  Eur Heart J       Date:  2015-06-01       Impact factor: 29.983

Review 4.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

5.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  Extra-corporeal membrane oxygenation and outcomes in massive pulmonary embolism: Two eras at an urban tertiary care hospital.

Authors:  David L Ain; Mazen Albaghdadi; Jay Giri; Farhad Abtahian; Michael R Jaff; Kenneth Rosenfield; Nathalie Roy; Mauricio Villavicencio-Theoduloz; Thoralf Sundt; Ido Weinberg
Journal:  Vasc Med       Date:  2017-11-10       Impact factor: 3.239

7.  The impact of a multi-specialty team for high risk pulmonary embolism on resident and fellow education.

Authors:  Ayman Elbadawi; Colin Wright; Dhwani Patel; Yu Lin Chen; Justin Mazzillo; Pamela Cameron; Geoffrey D Barnes; Scott J Cameron
Journal:  Vasc Med       Date:  2018-05-22       Impact factor: 3.239

8.  Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused.

Authors:  Paul D Stein; Fadi Matta
Journal:  Am J Med       Date:  2012-02-10       Impact factor: 4.965

9.  Pulmonary Embolism with Right Ventricular Dysfunction: Who Should Receive Thrombolytic Agents?

Authors:  Hem Desai; Bhupinder Natt; Christian Bime; Joshua Dill; James E Dalen; Joseph S Alpert
Journal:  Am J Med       Date:  2016-08-24       Impact factor: 4.965

10.  A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism.

Authors:  Christopher Kabrhel; Rachel Rosovsky; Richard Channick; Michael R Jaff; Ido Weinberg; Thoralf Sundt; David M Dudzinski; Josanna Rodriguez-Lopez; Blair A Parry; Savanah Harshbarger; Yuchiao Chang; Kenneth Rosenfield
Journal:  Chest       Date:  2016-03-19       Impact factor: 9.410

View more
  7 in total

1.  Massive pulmonary embolism with intra-hospital cardiac arrest and full recovery of right ventricular function after veno-arterial extracorporeal membrane oxygenation therapy: a case report.

Authors:  Stephan Camen; Gerold Söffker; Stefan Kluge; Elvin Zengin
Journal:  Eur Heart J Case Rep       Date:  2020-08-03

Review 2.  Extracorporeal Membrane Oxygenation Utility in Postpartum Patients.

Authors:  Bindu Akkanti; Ismael A Salas De Armas; Ayaaz K Sachedina; Jennifer M Sunny; Mahmoud Samy Ahmed; Avaleen Kaur; Kha T Dinh; Rahat Hussain; Sachin Kumar; Sriram Nathan; Marwan Jumean; Manish K Patel; Mehmet H Akay; Jayeshkumar A Patel; Barbi Witz; John Zaki; Igor Banjac; Lisa Janowiak; Igor D Gregoric; Biswajit Kar
Journal:  J Extra Corpor Technol       Date:  2020-09

3.  Survival of Children With Pulmonary Embolism Supported by Extracorporeal Membrane Oxygenation.

Authors:  John S Kim; Cindy S Barrett; Robert W Hyslop; Shannon M Buckvold; Katja M Gist
Journal:  Front Pediatr       Date:  2022-05-03       Impact factor: 3.418

4.  Future perspectives in catheter-based treatment of pulmonary embolism.

Authors:  Andrew S P Sharp; Antonious Attallah
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

5.  Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus.

Authors:  Daniel Lachant; Christina Bach; Bennett Wilson; Vaseem Chengazi; Bruce Goldman; Neil Lachant; Anthony Pietropaoli; Scott Cameron; R James White
Journal:  Pulm Circ       Date:  2020-09-21       Impact factor: 2.886

6.  Efficacy and Safety of Veno-Arterial Extracorporeal Membrane Oxygenation in the Treatment of High-Risk Pulmonary Embolism: A Retrospective Cohort Study.

Authors:  Hao-Yu Tsai; Yu-Tang Wang; Wei-Chieh Lee; Hsu-Ting Yen; Chien-Ming Lo; Chia-Chen Wu; Kwan-Ru Huang; Yin-Chia Chen; Jiunn-Jye Sheu; Yen-Yu Chen
Journal:  Front Cardiovasc Med       Date:  2022-03-02

Review 7.  Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism: a Meta-Analysis and Call to Action.

Authors:  Elona Rrapo Kaso; Jonathan A Pan; Michael Salerno; Alexandra Kadl; Chad Aldridge; Ziv J Haskal; Jamie L W Kennedy; Sula Mazimba; Andrew D Mihalek; Nicholas R Teman; Jay Giri; Herbert D Aronow; Aditya M Sharma
Journal:  J Cardiovasc Transl Res       Date:  2021-07-19       Impact factor: 3.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.